Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Nov 15;127(22):4240-4248.
doi: 10.1002/cncr.33832. Epub 2021 Aug 3.

Higher severity and risk of in-hospital mortality for COVID-19 patients with cancer during the year 2020 in Brazil: A countrywide analysis of secondary data

Guilherme Jorge Costa  1   2 , Carla Rameri Alexandre Silva de Azevedo  3   4 , José Iran Costa Júnior  3   4 , Anke Bergmann  5 , Luiz Claudio Santos Thuler  5
Affiliations

Higher severity and risk of in-hospital mortality for COVID-19 patients with cancer during the year 2020 in Brazil: A countrywide analysis of secondary data

Guilherme Jorge Costa et al. Cancer. .

Abstract

Background: Coronavirus disease 2019 (COVID-19) and cancer are serious public health problems worldwide. However, little is known about the risk factors of in-hospital mortality among COVID-19 patients with and without cancer in Brazil. The objective of this study was to evaluate the risk factors of in-hospital mortality among COVID-19 patients with and without cancer and to compare mortality according to gender and topography during the year 2020 in Brazil.

Methods: This was a secondary data study of hospitalized adult patients with a diagnosis of COVID-19 by real-time polymerase chain reaction testing in Brazil. The data were collected from the Influenza Epidemiological Surveillance Information System.

Results: This study analyzed data from 322,817 patients. The prevalence of cancer in patients with COVID-19 was 2.3%. COVID-19 patients with neurological diseases and cancer had the most lethal comorbidities in both sexes. COVID-19 patients with cancer were more likely to be older (median age, 67 vs 62 years; P < .001), to have a longer hospital stay (13.1 vs 11.5 days; P < .001), to be admitted to the intensive care unit (45.3% vs 39.6%; P < .001), to receive more invasive mechanical ventilation (27.1% vs 21.9%), and to have a higher risk of death (adjusted odds ratio [aOR], 1.94; 95% confidence interval [CI], 1.83-2.06; P < .001) than those without cancer. Patients with hematological neoplasia (aOR, 2.85; 95% CI, 2.41-3.38; P < .001) had a higher risk of mortality than those with solid tumors (aOR, 1.83; 95% CI, 1.72-1.95; P < .001) in both sexes.

Conclusions: Brazilian COVID-19 patients with cancer have higher disease severity and a higher risk of mortality than those without cancer.

Keywords: Brazil; cancer; coronavirus disease 2019 (COVID-19); mortality; prevalence; risk factors.

PubMed Disclaimer

Conflict of interest statement

The authors made no disclosures.

Figures

Figure 1
Figure 1
Flowchart of the SIVEP‐Gripe data used in this study. RT‐PCR indicates real‐time polymerase chain reaction; SARS‐CoV‐2, severe acute respiratory syndrome coronavirus 2; SIVEP‐Gripe, Sistema de Informação de Vigilância Epidemiológica da Gripe.
Figure 2
Figure 2
Percent distributions according to cancer patients versus noncancer patients: (A) overall in‐hospital mortality (P < .001), (B) admission to the ICU (P < .001), and (C) invasive mechanical ventilation (P < .001). ICU indicates intensive care unit.
Figure 3
Figure 3
Percent distributions of the lethality of different comorbidities according to sex.
Figure 4
Figure 4
Adjusted odds ratios and 95% confidence intervals for mortality in patients with coronavirus disease 2019 according to the topography of cancer.
See this image and copyright information in PMC

References

    1. World Health Organization . Accessed January 17, 2021. https://www.who.int/
    1. Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209‐249. doi:10.3322/caac.21660 - DOI - PubMed
    1. Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2021. CA Cancer J Clin. 2021;71:7‐33. doi:10.3322/caac.21654 - DOI - PubMed
    1. De Melo AC, Thuler LCS, Da Silva JL, et al. Cancer in patients with COVID‐19: a report from the Brazilian National Cancer Institute. PLoS One. 2020;15:0241261. doi:10.1371/journal.pone.0241261 - DOI - PMC - PubMed
    1. Meng Y, Meng Y, Lu W, et al. Cancer history is an independent risk factor for mortality in hospitalized COVID‐19 patients: a propensity score–matched analysis. J Hematol Oncol. 2020;13:75. doi:10.1186/s13045-020-00907-0 - DOI - PMC - PubMed

MeSH terms